Pharmacology - Jul 18
Novartis delivers strong sales, double digit core operating income growth and launches Zolgensma and Piqray in second quarter; sales and profit guidance increased
Novartis delivers strong sales, double digit core operating income growth and launches Zolgensma and Piqray in second quarter; sales and profit guidance increased
wire - news in brief
« BACK
Continuing Education - Innovation / Technology - 13.04.2018
Continuing Education
Result 1 - 1 of 1.
- Academic Rankings
- Administration
- Agronomy
- Business/Economics
- Career
- Chemistry
- Civil Engineering
- Computer Science
- Earth Sciences
- Electroengineering
- Environment
- Health
- Innovation
- Interdisciplinary
- Life Sciences
- Materials Science
- Mathematics
- Mechanical Engineering
- Media
- Pedagogy
- Physics
- Psychology
- Social Sciences
- Sport Sciences
- Veterinary Science
Pharmacology - Jul 18
Novartis delivers strong sales, double digit core operating income growth and launches Zolgensma and Piqray in second quarter; sales and profit guidance increased
Novartis delivers strong sales, double digit core operating income growth and launches Zolgensma and Piqray in second quarter; sales and profit guidance increased